Geraldina Visconti
Examiner (ID: 121, Phone: (571)272-1334 , Office: P/1722 )
Most Active Art Unit | 1722 |
Art Unit(s) | 1506, 1795, 1752, 1113, 1722 |
Total Applications | 2553 |
Issued Applications | 2180 |
Pending Applications | 89 |
Abandoned Applications | 284 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 6870113
[patent_doc_number] => 20030082802
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-01
[patent_title] => ' METHOD FOR NEURAL STEM CELL DIFFERENTIATION USING 5HT1A AGONISTS\n '
[patent_app_type] => original-publication-amended
[patent_app_number] => 10/175360
[patent_app_country] => US
[patent_app_date] => 2002-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 15488
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20030082802.pdf
[firstpage_image] =>[orig_patent_app_number] => 10175360
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/175360 | Method for neural stem cell differentiation using 5HT-1A agonists | Jun 17, 2002 | Issued |
10/048499 | Neutral cerebral-sphingomyelinase | Jun 17, 2002 | Abandoned |
Array
(
[id] => 6774150
[patent_doc_number] => 20030017488
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-23
[patent_title] => 'Method for testing a therapeutic or preventive agent for hyperlipidemia'
[patent_app_type] => new
[patent_app_number] => 10/164030
[patent_app_country] => US
[patent_app_date] => 2002-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 24812
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0017/20030017488.pdf
[firstpage_image] =>[orig_patent_app_number] => 10164030
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/164030 | Method for testing a therapeutic or preventive agent for hyperlipidemia | Jun 5, 2002 | Abandoned |
Array
(
[id] => 6750460
[patent_doc_number] => 20030044980
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-06
[patent_title] => 'Methods for low background cloning of DNA using long oligonucleotides'
[patent_app_type] => new
[patent_app_number] => 10/164297
[patent_app_country] => US
[patent_app_date] => 2002-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 25759
[patent_no_of_claims] => 107
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0044/20030044980.pdf
[firstpage_image] =>[orig_patent_app_number] => 10164297
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/164297 | Methods for low background cloning of DNA using long oligonucleotides | Jun 4, 2002 | Abandoned |
Array
(
[id] => 663698
[patent_doc_number] => 07101995
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-09-05
[patent_title] => 'Compositions and processes using siRNA, amphipathic compounds and polycations'
[patent_app_type] => utility
[patent_app_number] => 10/157674
[patent_app_country] => US
[patent_app_date] => 2002-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 10
[patent_no_of_words] => 12002
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/101/07101995.pdf
[firstpage_image] =>[orig_patent_app_number] => 10157674
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/157674 | Compositions and processes using siRNA, amphipathic compounds and polycations | May 27, 2002 | Issued |
Array
(
[id] => 1340748
[patent_doc_number] => 06586237
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-07-01
[patent_title] => 'Compositions and methods for cloning nucleic acids'
[patent_app_type] => B1
[patent_app_number] => 10/154710
[patent_app_country] => US
[patent_app_date] => 2002-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 13741
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/586/06586237.pdf
[firstpage_image] =>[orig_patent_app_number] => 10154710
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/154710 | Compositions and methods for cloning nucleic acids | May 23, 2002 | Issued |
Array
(
[id] => 6791920
[patent_doc_number] => 20030087264
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-08
[patent_title] => 'Transcriptional regulation of target genes'
[patent_app_type] => new
[patent_app_number] => 10/151702
[patent_app_country] => US
[patent_app_date] => 2002-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9080
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20030087264.pdf
[firstpage_image] =>[orig_patent_app_number] => 10151702
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/151702 | Transcriptional regulation of target genes | May 19, 2002 | Abandoned |
Array
(
[id] => 6696695
[patent_doc_number] => 20030108889
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-12
[patent_title] => 'Method for generating diversity'
[patent_app_type] => new
[patent_app_number] => 10/146505
[patent_app_country] => US
[patent_app_date] => 2002-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 20635
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0108/20030108889.pdf
[firstpage_image] =>[orig_patent_app_number] => 10146505
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/146505 | Method for generating diversity | May 14, 2002 | Issued |
Array
(
[id] => 6735516
[patent_doc_number] => 20030013151
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-16
[patent_title] => 'Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/143576
[patent_app_country] => US
[patent_app_date] => 2002-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 19036
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0013/20030013151.pdf
[firstpage_image] =>[orig_patent_app_number] => 10143576
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/143576 | Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof | May 12, 2002 | Abandoned |
Array
(
[id] => 7182913
[patent_doc_number] => 20040203010
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-14
[patent_title] => 'Compositions and methods for gender sorting'
[patent_app_type] => new
[patent_app_number] => 10/475433
[patent_app_country] => US
[patent_app_date] => 2004-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 16497
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 166
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20040203010.pdf
[firstpage_image] =>[orig_patent_app_number] => 10475433
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/475433 | Compositions and methods for gender sorting | Apr 22, 2002 | Issued |
Array
(
[id] => 6710898
[patent_doc_number] => 20030170647
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-11
[patent_title] => 'Nucleic acid encoding a retinoblastoma binding protein (RBP-7) and polymorphic markers associated with said nucleic acid'
[patent_app_type] => new
[patent_app_number] => 10/126704
[patent_app_country] => US
[patent_app_date] => 2002-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 43081
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20030170647.pdf
[firstpage_image] =>[orig_patent_app_number] => 10126704
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/126704 | Nucleic acid encoding a retinoblastoma binding protein (RBP-7) and polymorphic markers associated with said nucleic acid | Apr 19, 2002 | Abandoned |
Array
(
[id] => 7212288
[patent_doc_number] => 20050054102
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-10
[patent_title] => 'Method for differentiating stem cells into insulin-producing cells'
[patent_app_type] => utility
[patent_app_number] => 10/475021
[patent_app_country] => US
[patent_app_date] => 2002-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 8481
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20050054102.pdf
[firstpage_image] =>[orig_patent_app_number] => 10475021
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/475021 | Method for differentiating stem cells into insulin-producing cells | Apr 18, 2002 | Abandoned |
Array
(
[id] => 7149382
[patent_doc_number] => 20040170976
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-02
[patent_title] => 'Solubility reporter gene constructs'
[patent_app_type] => new
[patent_app_number] => 10/127078
[patent_app_country] => US
[patent_app_date] => 2002-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 15435
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20040170976.pdf
[firstpage_image] =>[orig_patent_app_number] => 10127078
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/127078 | Solubility reporter gene constructs | Apr 18, 2002 | Abandoned |
Array
(
[id] => 623477
[patent_doc_number] => 07138267
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-11-21
[patent_title] => 'Methods and compositions for amplifying DNA clone copy number'
[patent_app_type] => utility
[patent_app_number] => 10/116886
[patent_app_country] => US
[patent_app_date] => 2002-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12074
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/138/07138267.pdf
[firstpage_image] =>[orig_patent_app_number] => 10116886
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/116886 | Methods and compositions for amplifying DNA clone copy number | Apr 3, 2002 | Issued |
Array
(
[id] => 6693066
[patent_doc_number] => 20030040498
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-27
[patent_title] => 'Oncolytic RNA replicons'
[patent_app_type] => new
[patent_app_number] => 10/097058
[patent_app_country] => US
[patent_app_date] => 2002-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 16644
[patent_no_of_claims] => 112
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20030040498.pdf
[firstpage_image] =>[orig_patent_app_number] => 10097058
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/097058 | Oncolytic RNA replicons | Mar 12, 2002 | Abandoned |
Array
(
[id] => 7455265
[patent_doc_number] => 20040068095
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-08
[patent_title] => 'Novel human proteins, polynucleotides encoding them and methods of using the same'
[patent_app_type] => new
[patent_app_number] => 10/096625
[patent_app_country] => US
[patent_app_date] => 2002-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 105763
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20040068095.pdf
[firstpage_image] =>[orig_patent_app_number] => 10096625
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/096625 | Novel human proteins, polynucleotides encoding them and methods of using the same | Mar 12, 2002 | Abandoned |
Array
(
[id] => 6735547
[patent_doc_number] => 20030013182
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-16
[patent_title] => 'Methods for isolating genes from microorganisms'
[patent_app_type] => new
[patent_app_number] => 10/095975
[patent_app_country] => US
[patent_app_date] => 2002-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 20710
[patent_no_of_claims] => 63
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0013/20030013182.pdf
[firstpage_image] =>[orig_patent_app_number] => 10095975
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/095975 | Methods for isolating genes from microorganisms | Mar 11, 2002 | Issued |
Array
(
[id] => 6751175
[patent_doc_number] => 20030045696
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-06
[patent_title] => 'Orphanin FQ receptor nucleic acids'
[patent_app_type] => new
[patent_app_number] => 10/087345
[patent_app_country] => US
[patent_app_date] => 2002-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 22805
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20030045696.pdf
[firstpage_image] =>[orig_patent_app_number] => 10087345
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/087345 | Orphanin FQ receptor nucleic acids | Feb 28, 2002 | Issued |
Array
(
[id] => 1273257
[patent_doc_number] => 06649367
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-11-18
[patent_title] => 'Human cancer cell line malignantly altered by expression of angiogenic factor'
[patent_app_type] => B2
[patent_app_number] => 10/084686
[patent_app_country] => US
[patent_app_date] => 2002-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 5903
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/649/06649367.pdf
[firstpage_image] =>[orig_patent_app_number] => 10084686
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/084686 | Human cancer cell line malignantly altered by expression of angiogenic factor | Feb 25, 2002 | Issued |
Array
(
[id] => 6778568
[patent_doc_number] => 20030049649
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-13
[patent_title] => 'Targeted modification of chromatin structure'
[patent_app_type] => new
[patent_app_number] => 10/084826
[patent_app_country] => US
[patent_app_date] => 2002-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 34132
[patent_no_of_claims] => 73
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20030049649.pdf
[firstpage_image] =>[orig_patent_app_number] => 10084826
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/084826 | Targeted modification of chromatin structure | Feb 23, 2002 | Abandoned |